Karaganda pharmaceutical complex begins production of Sputnik Light

03 March


Kazakhstan's Karaganda Pharmaceutical Complex (KPC) is starting to produce a Russian single-component vaccine against coronavirus Sputnik Light, the company's press service announced on Thursday.


"The pharmaceutical complex begins production of the Sputnik Light single-component vaccine. Validation batches of this vaccine have already been produced at KPC and sent for quality control in Russia," the press service said in a Telegram message.


The agency reminded that the KPC already has experience in the production of the Russian vaccine against coronavirus Sputnik V. "It is worth noting that it was the KPC that produced the first batches of Sputnik V for the vaccination of Kazakhstanis against coronavirus infection. Since February 2021, 7 million doses of the much-needed vaccine have been sent to civilian circulation to combat the spread of infection during the pandemic. The next step is to establish production of a single-component drug Sputnik Light for revaccination of the population," the press service explained.


Sputnik Light, developed at the Russian Gamaleya Research Institute, was registered in Kazakhstan in July 2021. Earlier, Bauyrzhan Baiserkin, chairman of the Medical and Pharmaceutical Control Committee of the Ministry of Health of the Republic of Kazakhstan, said that the KPC plans to produce Sputnik Light from the substance to be imported from Russia.

 

 

GSV "Russia - Islamic world"

Photo: EPA/ANATOLY MALTSEV/TASS

Based on materials from TASS